Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Medical Center Groningen
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years
WHO PS 0-2
Histological or cytological confirmation of non-small cell lung cancer or an 18F-FDG-positive, growing mass on CT-thorax suggestive of NSCLC.
Stage IIIA or IIIB
Patients with extensive mediastinal lymph node involvement (such as N3), or large primary tumour size
Adequate pulmonary function estimated by flow volume curves
Life expectancy of at least 6 months
Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol; those conditions should be discussed with the patient before registration in the trial.
Planned for 25 x 2.4 Gy, with concomitant chemotherapy
Before patient registration, written informed consent will be obtained.
You may not be if
Presence of contra-indications for undergoing MRI
Clareo Health | Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
